Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Cannabidiol
Therapeutic Area : Psychiatry/Psychology
Study Phase : Approved FDF
Sponsor : Vectura Fertin Pharma
Deal Size : Inapplicable
Deal Type : Inapplicable
Aurora Cannabis and Vectura Fertin Pharma, Inc. Announce Launch of Novel Luo CBD Lozenge
Details :
Product Name : Luo CBD Lozenge
Product Type : Controlled Substance
Upfront Cash : Inapplicable
September 09, 2024
Lead Product(s) : Cannabidiol
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Approved FDF
Sponsor : Vectura Fertin Pharma
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Cannabidiol
Therapeutic Area : Neurology
Study Phase : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Aurora Cannabis Launches its First Medical CBD Product in Uruguay
Details :
Product Name : Luo CBD Lozenge
Product Type : Controlled Substance
Upfront Cash : Inapplicable
September 29, 2021
Lead Product(s) : Cannabidiol
Therapeutic Area : Neurology
Highest Development Status : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable